REFERENCES
1. Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014;16(9):1257-1283.
2. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I f current inhibition with ivabradine. Drugs. 2004;64(16):1757-1765.
3. Fox K, Ford I, Steg PG, Tendera M, Ferrari R, Investigators B. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. The Lancet. 2008;372(9641):807-816.
4. Fox K, Ford I, Steg PG, Tardif J-C, Tendera M, Ferrari R. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med. 2014;371(12):1091-1099.
5. Calò L, Rebecchi M, Sette A, et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm. 2010;7(9):1318-1323.
6. Bohora S, Lokhandwala Y, Parekh P, Vasavda A. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. J Cardiovasc Electrophysiol. 2011;22(3):340-342.
7. Kumar V, Kumar G, Tiwari N, Joshi S, Sharma V, Ramamurthy R. Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study. World Journal for Pediatric and Congenital Heart Surgery. 2019;10(6):709-714.
8. Tekkeşin Aİ, Gürkan K, Alper AT, Türkkan C, Özbilgin N. Ivabradine Terminated Incessant Right and Left Atrial Tachycardia. J Am Coll Cardiol. 2013;62(18 Supplement 2):C47-C48.
9. Enriquez A, Malavassi F, Saenz LC, et al. How to map and ablate left ventricular summit arrhythmias. Heart Rhythm. 2017;14(1):141-148.
10. Yamada T, McElderry HT, Doppalapudi H, et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation. Circulation: Arrhythmia and Electrophysiology. 2010;3(6):616-623.
11. Dukes JW, Dewland TA, Vittinghoff E, et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015;66(2):101-109.
12. Lee A, Walters TE, Gerstenfeld EP, Haqqani HM. Frequent ventricular ectopy: Implications and Outcomes. Heart, Lung and Circulation. 2019;28(1):178-190.
13. Savelieva I, Camm AJ. I f Inhibition with Ivabradine. Drug Saf. 2008;31(2):95-107.
14. Wahl-Schott C, Biel M. HCN channels: structure, cellular regulation and physiological function. Cell Mol Life Sci. 2009;66(3):470.
15. Yasui K, Liu W, Opthof T, et al. I f current and spontaneous activity in mouse embryonic ventricular myocytes. Circ Res. 2001;88(5):536-542.
16. Stillitano F, Lonardo G, Zicha S, et al. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol. 2008;45(2):289-299.
17. Chen S-A, Hsieh M-H, Tai C-T, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999;100(18):1879-1886.
18. Turley SL, Francis KE, Lowe DK, Cahoon Jr WD. Emerging role of ivabradine for rate control in atrial fibrillation. Ther Adv Cardiovasc Dis. 2016;10(6):348-352.
19. Banavalikar B, Shenthar J, Padmanabhan D, et al. Clinical and Electrophysiological Correlates of Incessant Ivabradine-Sensitive Atrial Tachycardia. Circulation: Arrhythmia and Electrophysiology. 2019;12(8):e007387.
20. Kohli U, Aziz Z, Beaser AD, Nayak HM. Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy. Pacing Clin Electrophysiol. 2020.
21. Mughal LH, Houghton AR, Khoo J. Significant suppression of premature ventricular ectopics with ivabradine in dilated cardiomyopathy.
22. Melgari D, Brack KE, Zhang C, et al. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine. Journal of the American Heart Association. 2015;4(4):e001813.
23. Mackiewicz U, Gerges JY, Chu S, et al. Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat. J Cell Physiol. 2014;229(6):813-823.